Facilitating Clinical Studies in Rare Diseases
- 7 December 2017
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 1031, 125-140
- https://doi.org/10.1007/978-3-319-67144-4_6
Abstract
In recent years, there have been many scientific advances and new collaborations for rare diseases research and, ultimately, the health of patients living with rare diseases. However, for too many rare diseases, there still is no effective treatment, and our understanding of the incidence, prevalence, and underlying etiology is incomplete. To facilitate the studies needed to answer the many open questions there is a great need for the active involvement of all stakeholders, most importantly of patient groups. Also, the creation of streamlined infrastructure for performing multi-site clinical studies is critical, as is the engagement of multi-disciplinary teams with shared focus on a group of diseases. Another essential component of such efforts is to collect standardized data so that downstream meta-analyses and data sharing can be facilitated. To ensure high-quality protocols and datasets, a central data management and coordinating center is important. Since there are more than 6000 rare diseases, instead of focusing on single rare disease, it is more impactful to create platforms and methods that can support a group of rare diseases.Keywords
This publication has 14 references indexed in Scilit:
- Afamelanotide for Erythropoietic ProtoporphyriaThe New England Journal of Medicine, 2015
- The Rare Diseases Clinical Research Network’s Organization and Approach to Observational Research and Health Outcomes ResearchJournal of General Internal Medicine, 2014
- Prospective study of muscle cramps in Charcot‐Marie‐Tooth diseaseMuscle & Nerve, 2014
- Quality-of-life in Charcot–Marie–Tooth disease: The patient’s perspectiveNeuromuscular Disorders, 2014
- Rare Diseases Challenges and OpportunitiesCommunications in Medical and Care Compunetics, 2013
- Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachKidney International, 2013
- Pregnancy Outcomes Among Patients With VasculitisArthritis Care & Research, 2013
- Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHDTransplantation and Cellular Therapy, 2011
- Efficacy and Safety of Sirolimus in LymphangioleiomyomatosisThe New England Journal of Medicine, 2011
- Clinical research for rare disease: Opportunities, challenges, and solutionsMolecular Genetics and Metabolism, 2009